Global Health Ltd vs Molbio Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Global Health Ltd is ₹ 1184 as of 23 Oct 15:30 . The P/E Ratio of Global Health Ltd changed from 43.3 on March 2023 to 46.4 on March 2026 . This represents a CAGR of 1.74% over 4 yearsThe P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Global Health Ltd changed from ₹ 14111 crore on March 2023 to ₹ 25850 crore on March 2026 . This represents a CAGR of 16.34% over 4 yearsThe Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Global Health Ltd for the Jun '26 is ₹ 1326 crore as compare to the Mar '26 revenue of ₹ 1195 crore. This represent the growth of 10.91% The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The ebitda of Global Health Ltd for the Jun '26 is ₹ 308.92 crore as compare to the Mar '26 ebitda of ₹ 280.51 crore. This represent the growth of 10.13% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The net profit of Global Health Ltd changed from ₹ 106.26 crore to ₹ 157.25 crore over 9 quarters. This represents a CAGR of 19.03% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The Dividend Payout of Global Health Ltd changed from 2.71 % on March 2026 to 2.71 % on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Global Health Ltd

Global Health Limited (GHL) was incorporated as Global Health Private Limited' on August 13, 2004 at New Delhi, India as a Private Company.
The status of the Company got converted into a Public Limited Company and the name was changed to Global Health Limited' dated August 11, 2021 issued by the RoC. Presently, the Company is engaged in providing healthcare services. The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon.
The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly.

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

FAQs for the comparison of Global Health Ltd and null

Which company has a larger market capitalization, Global Health Ltd or Molbio Diagnostics Ltd?

Market cap of Global Health Ltd is 31,850 Cr while Market cap of Molbio Diagnostics Ltd is 14,262 Cr

What are the key factors driving the stock performance of Global Health Ltd and Molbio Diagnostics Ltd?

The stock performance of Global Health Ltd and Molbio Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Global Health Ltd and Molbio Diagnostics Ltd?

As of October 24, 2026, the Global Health Ltd stock price is INR ₹1184.6. On the other hand, Molbio Diagnostics Ltd stock price is INR ₹1237.65.

How do dividend payouts of Global Health Ltd and Molbio Diagnostics Ltd compare?

To compare the dividend payouts of Global Health Ltd and Molbio Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.